{
  "entities": [
    {
      "id": "E1",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.95,
      "evidence": "substance use disorders",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "immune signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.85,
      "evidence": "dysregulated immune signaling",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "neuroimmune interactions",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.8,
      "evidence": "neuroimmune interactions",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "immune mediators",
      "attributes": {
        "target_type": "mediator"
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.75,
      "evidence": "immune mediators",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "brain-immune system interactions",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.7,
      "evidence": "brain-immune system interactions",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "immunological changes",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.8,
      "evidence": "immunological changes",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "addictive behaviors",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.85,
      "evidence": "addictive behaviors",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.9,
      "evidence": "In this review",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "review on immune signaling in substance use disorders",
      "attributes": {
        "design": "review"
      },
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "confidence": 0.85,
      "evidence": "In this review, we discuss",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "806dcc5849d9093c8e070d6c9679095a"
      ],
      "confidence": 0.95,
      "evidence": "Substance use disorders affect millions",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "overdose",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "806dcc5849d9093c8e070d6c9679095a"
      ],
      "confidence": 0.85,
      "evidence": "death from overdose",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "infectious disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "806dcc5849d9093c8e070d6c9679095a"
      ],
      "confidence": 0.85,
      "evidence": "spread of infectious disease",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "shorter life expectancies",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "806dcc5849d9093c8e070d6c9679095a"
      ],
      "confidence": 0.8,
      "evidence": "shorter life expectancies",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "806dcc5849d9093c8e070d6c9679095a"
      ],
      "confidence": 0.9,
      "evidence": "tremendous cost of addiction",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "pathological drug use",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "806dcc5849d9093c8e070d6c9679095a"
      ],
      "confidence": 0.85,
      "evidence": "rates of pathological drug use",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.95,
      "evidence": "substance use disorders",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "nicotine use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.9,
      "evidence": "nicotine use disorder",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "alcohol use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.9,
      "evidence": "alcohol use disorder",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "opioid use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.9,
      "evidence": "opioid use disorder",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "psychostimulant use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.9,
      "evidence": "psychostimulant use disorders",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "varenicline",
      "attributes": {},
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.85,
      "evidence": "Varenicline",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "bupropion",
      "attributes": {},
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.85,
      "evidence": "bupropion",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "naltrexone",
      "attributes": {},
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.85,
      "evidence": "naltrexone",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "acamprosate",
      "attributes": {},
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.85,
      "evidence": "acamprosate",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "disulfiram",
      "attributes": {},
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.85,
      "evidence": "disulfiram",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "methadone",
      "attributes": {},
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.85,
      "evidence": "methadone",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "buprenorphine",
      "attributes": {},
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.85,
      "evidence": "buprenorphine",
      "verified": true
    },
    {
      "id": "E13",
      "type": "AdverseEvent",
      "name": "adverse effects",
      "attributes": {
        "severity": "unspecified"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.8,
      "evidence": "adverse effects",
      "verified": true
    },
    {
      "id": "E14",
      "type": "AdverseEvent",
      "name": "sexual dysfunction",
      "attributes": {
        "severity": "undesirable"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.8,
      "evidence": "sexual dysfunction",
      "verified": true
    },
    {
      "id": "E15",
      "type": "AdverseEvent",
      "name": "weight gain",
      "attributes": {
        "severity": "undesirable"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.8,
      "evidence": "weight gain",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "dopaminergic systems",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.75,
      "evidence": "dopaminergic systems",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Study",
      "name": "G\u00f3mez-Coronado et al., 2018",
      "attributes": {
        "year": 2018
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.7,
      "evidence": "G\u00f3mez-Coronado et al., 2018",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Study",
      "name": "Soyka & M\u00fcller, 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.7,
      "evidence": "Soyka &amp; M\u00fcller, 2017",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Study",
      "name": "Mattick et al., 2014",
      "attributes": {
        "year": 2014
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.7,
      "evidence": "Mattick et al., 2014",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Study",
      "name": "Schuckit, 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.7,
      "evidence": "Schuckit, 2016",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Study",
      "name": "Castells et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.7,
      "evidence": "Castells et al., 2016",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Study",
      "name": "Tollefson, 1991",
      "attributes": {
        "year": 1991
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.7,
      "evidence": "Tollefson, 1991",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Study",
      "name": "Solmi et al., 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "confidence": 0.7,
      "evidence": "Solmi et al., 2017",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "multiple psychiatric illnesses",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.9,
      "evidence": "multiple psychiatric illnesses",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "immune system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.85,
      "evidence": "immune system",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "central nervous system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.85,
      "evidence": "central nervous system",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "depression",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.95,
      "evidence": "depression",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.95,
      "evidence": "schizophrenia",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "addictive disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.9,
      "evidence": "addictive disorders",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "illicit substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.9,
      "evidence": "illicit substance use disorders",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "neuroimmune processes",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.8,
      "evidence": "neuroimmune processes",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "inflammatory processes",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.8,
      "evidence": "inflammatory processes",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "immune or inflammatory treatment targets",
      "attributes": {
        "target_type": "target"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.75,
      "evidence": "immune or inflammatory treatment targets",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "psychiatric pathology",
      "attributes": {
        "condition_type": "pathology"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.85,
      "evidence": "psychiatric pathology",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "alcoholism",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "confidence": 0.9,
      "evidence": "alcoholism",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "immune system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.95,
      "evidence": "The immune system is the major regulator",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "innate immune system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.9,
      "evidence": "The innate immune system is available",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "adaptive immune system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.9,
      "evidence": "adaptive immune system is largely composed",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "pattern recognition receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.85,
      "evidence": "pattern recognition receptors (PRR)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.9,
      "evidence": "tissue resident macrophages called microglia",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.8,
      "evidence": "astrocytes have also been shown",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "pro-inflammatory cytokines",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.85,
      "evidence": "Pro-inflammatory cytokines (e.g., IL-1\u03b2 & TNF-\u03b1)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.8,
      "evidence": "IL-1\u03b2 & tumor necrosis factor-alpha",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.8,
      "evidence": "tumor necrosis factor-alpha, TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "anti-inflammatory cytokines",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.85,
      "evidence": "anti-inflammatory cytokines (e.g., IL-10)",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "IL-10",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.8,
      "evidence": "IL-10",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "inflammatory response",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.9,
      "evidence": "mount rapid inflammatory response",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "tissue damage",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.85,
      "evidence": "prolonged inflammation can cause tissue damage",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "chronic diseases",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.8,
      "evidence": "contributes to several chronic diseases",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "psychiatric pathologies",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "confidence": 0.8,
      "evidence": "including psychiatric pathologies",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "autism spectrum disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "confidence": 0.9,
      "evidence": "autism spectrum disorder",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "bipolar disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "confidence": 0.9,
      "evidence": "bipolar disorder",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "Alzheimer's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "confidence": 0.9,
      "evidence": "Alzheimer's disease",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "schizophrenia",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "confidence": 0.9,
      "evidence": "schizophrenia",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "confidence": 0.85,
      "evidence": "substance use disorders",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "neuroimmune interactions",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "confidence": 0.8,
      "evidence": "neuroimmune interactions",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "inflammatory changes",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "confidence": 0.75,
      "evidence": "inflammatory changes",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "changes in brain systems",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "confidence": 0.7,
      "evidence": "changes in brain systems",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.9,
      "evidence": "development of substance use disorders",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "dopamine signaling",
      "attributes": {
        "target_type": "signaling pathway"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.85,
      "evidence": "inflammatory changes can affect dopamine signaling",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Brydon et al., 2008",
      "attributes": {
        "year": 2008
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.8,
      "evidence": "Brydon et al., 2008",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.75,
      "evidence": "Healthy controls given a typhoid vaccination",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "substantia nigra",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.85,
      "evidence": "increased activation of their substantia nigra",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.8,
      "evidence": "increased serum levels of IL-6",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Capuron et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.8,
      "evidence": "Capuron et al., 2012",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "IFN-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.8,
      "evidence": "interferon-\u03b1 (IFN-\u03b1) pro-inflammatory cytokine",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "dopamine synthesis",
      "attributes": {
        "target_type": "biosynthetic process"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.85,
      "evidence": "decreasing dopamine synthesis",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "dopamine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.85,
      "evidence": "affect dopamine transporter function",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Felger & Miller, 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.8,
      "evidence": "Felger & Miller, 2012",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Felger & Treadway, 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.8,
      "evidence": "Felger & Treadway, 2017",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "mesolimbic dopamine release",
      "attributes": {
        "target_type": "neurotransmitter release"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.85,
      "evidence": "drugs of abuse all work via increasing mesolimbic dopamine release",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Chao & Nestler, 2004",
      "attributes": {
        "year": 2004
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.8,
      "evidence": "Chao & Nestler, 2004",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "inflammation",
      "attributes": {
        "target_type": "biological process"
      },
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "confidence": 0.9,
      "evidence": "inflammatory changes can affect dopamine signaling",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "inflammation",
      "attributes": {},
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.95,
      "evidence": "Inflammation has also been found",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "glutamatergic signaling",
      "attributes": {
        "target_type": "neurotransmitter system"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.9,
      "evidence": "affect glutamatergic signaling",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.85,
      "evidence": "key neurotransmitter system in drug addiction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "relapse",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.85,
      "evidence": "drug addiction and relapse",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "major depressive disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.9,
      "evidence": "patients with major depressive disorder",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decreased functional connectivity",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.8,
      "evidence": "decreased functional connectivity",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "glutamate transporters",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.9,
      "evidence": "glutamate transporters",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "downregulation of glutamate transporters",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.85,
      "evidence": "downregulate glutamate transporters",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "disruption of glutamate signaling homeostasis",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.8,
      "evidence": "disrupting the homeostasis of glutamate signaling",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Condition",
      "name": "cocaine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.8,
      "evidence": "animal models of addiction",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "increase in synaptic glutamate",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.75,
      "evidence": "increase in synaptic glutamate",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "TNF-\u03b1 cytokine",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.9,
      "evidence": "TNF-\u03b1 cytokine",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "regulation of synaptic strength",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.8,
      "evidence": "regulator of synaptic strength",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "corticostriatal signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.85,
      "evidence": "corticostriatal signaling",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "confidence": 0.9,
      "evidence": "substance use disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.95,
      "evidence": "cocaine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Compound",
      "name": "amphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.9,
      "evidence": "amphetamines",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "dopamine transporter",
      "attributes": {
        "target_type": "transporter"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.9,
      "evidence": "dopamine transporter",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "dopamine receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.85,
      "evidence": "dopamine receptor",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "PRRs",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.8,
      "evidence": "PRRs",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "HIV replication",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.85,
      "evidence": "HIV replication rates",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "hypothalamic-pituitary-adrenal axis",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.9,
      "evidence": "hypothalamic-pituitary-adrenal axis",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increase dopamine levels",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.85,
      "evidence": "increase levels of dopamine",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "affect cytokine production",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.8,
      "evidence": "affect their production of cytokines",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "inflammatory response",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.85,
      "evidence": "create an inflammatory response",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "increase HIV replication",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.9,
      "evidence": "increases HIV replication rates",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "release cortisol",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.85,
      "evidence": "release of cortisol",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "anti-inflammatory effects",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.8,
      "evidence": "acutely anti-inflammatory effects",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "pro-inflammatory effects",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.8,
      "evidence": "chronically pro-inflammatory effects",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "affect immune function",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.85,
      "evidence": "affect immune function",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "confidence": 0.9,
      "evidence": "addictive behaviors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "psychostimulant use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.9,
      "evidence": "psychostimulant use disorder",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "cocaine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.85,
      "evidence": "cocaine addicts",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "methamphetamine use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.85,
      "evidence": "methamphetamine use disorder",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "central pro-inflammatory mechanism",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.8,
      "evidence": "central pro-inflammatory mechanism",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increased markers of microglial activation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.8,
      "evidence": "increased markers of microglial activation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decreased number of dopamine cell bodies",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.8,
      "evidence": "decreased number of dopamine cell bodies",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Little et al., 2009",
      "attributes": {
        "design": "postmortem examination",
        "year": 2009
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.85,
      "evidence": "Little et al., 2009",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Sekine et al., 2008",
      "attributes": {
        "design": "PET study",
        "year": 2008
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.85,
      "evidence": "Sekine et al., 2008",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Evidence",
      "name": "postmortem examination",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.8,
      "evidence": "Postmortem examination",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "PET study",
      "attributes": {
        "evidence_level": 4
      },
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "confidence": 0.8,
      "evidence": "PET studies",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Narendran et al., 2014",
      "attributes": {
        "year": 2014
      },
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "confidence": 0.9,
      "evidence": "Narendran et al., 2014",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "PET imaging study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "confidence": 0.8,
      "evidence": "PET tracers",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "cocaine use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "confidence": 0.95,
      "evidence": "patients with cocaine use disorder",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "microglial radiotracers",
      "attributes": {
        "target_type": "radiotracer"
      },
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "confidence": 0.85,
      "evidence": "microglial radiotracers",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Cosenza-Nashat et al., 2009",
      "attributes": {
        "year": 2009
      },
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "confidence": 0.9,
      "evidence": "Cosenza-Nashat et al., 2009",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Lacagnina et al., 2017b",
      "attributes": {},
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.8,
      "evidence": "reviewed more extensively by Lacagnina et al., (2017b)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.75,
      "evidence": "reviewed more extensively by Lacagnina et al., (2017b)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.9,
      "evidence": "activating microglia",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.85,
      "evidence": "psychostimulant activation of astrocytes",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "glial cells",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.8,
      "evidence": "other glial cells",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "methamphetamine",
      "attributes": {},
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.95,
      "evidence": "Methamphetamine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Thanos et al., 2016",
      "attributes": {},
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.85,
      "evidence": "Thanos et al., 2016",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "microglial activation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.9,
      "evidence": "induce microglial activation",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "minocycline",
      "attributes": {},
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.9,
      "evidence": "anti-inflammatory antibiotic minocycline",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.9,
      "evidence": "ibudilast",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "TLR-4",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.85,
      "evidence": "toll-like receptor 4 (TLR-4)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "reduced rewarding properties of stimulants",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.8,
      "evidence": "reduce the rewarding properties of stimulants",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Chen et al., 2009; Snider et al., 2013; Attarzadeh-Yazdi et al., 2014",
      "attributes": {},
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "confidence": 0.8,
      "evidence": "Chen et al., 2009; Snider et al., 2013; Attarzadeh-Yazdi et al., 2014",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.95,
      "evidence": "cocaine in particular may bind to TLR4",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "TLR4",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.95,
      "evidence": "TLR4, a PRR expressed on microglia",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Zhang et al., 2014",
      "attributes": {
        "year": 2014
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.9,
      "evidence": "Zhang et al., 2014",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Northcutt et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.9,
      "evidence": "Northcutt et al., (2015)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "in silico and in vitro modeling",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.85,
      "evidence": "in silico and in vitro modeling",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "dopamine release",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.8,
      "evidence": "cocaine-induced dopamine release",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "conditioned place preference",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.8,
      "evidence": "conditioned place preference (CPP)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.8,
      "evidence": "self-administration of cocaine",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Kashima & Grueter, 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.9,
      "evidence": "Kashima & Grueter, 2017",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "basal synaptic transmission",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.75,
      "evidence": "basal synaptic transmission",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "NMDA-dependent synaptic plasticity",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.75,
      "evidence": "NMDA-dependent synaptic plasticity",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Brown et al., 2018",
      "attributes": {
        "year": 2018
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.9,
      "evidence": "Brown et al., 2018",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "reinstatement of cocaine seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.8,
      "evidence": "reinstatement of cocaine seeking",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Tanda et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.9,
      "evidence": "Tanda et al., 2016",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "(+)-naloxone",
      "attributes": {},
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.9,
      "evidence": "TLR4 antagonists (+)-naloxone",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "confidence": 0.85,
      "evidence": "neurobiology of addiction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "TLR signaling",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.9,
      "evidence": "studies on TLR signaling",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "cytokine and chemokine signaling",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.85,
      "evidence": "role of cytokine and chemokine signaling",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "G-CSF",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.95,
      "evidence": "granulocyte colony-stimulating factor (G-CSF)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "psychostimulant use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.9,
      "evidence": "models of psychostimulant use disorders",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increased neuronal activation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.8,
      "evidence": "increased neuronal activation in the NAc and prefrontal cortex",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "enhanced cocaine CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.85,
      "evidence": "G-CSF enhanced cocaine CPP",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "locomotor sensitization",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.85,
      "evidence": "G-CSF enhanced locomotor sensitization",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.85,
      "evidence": "G-CSF enhanced self-administration",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Calipari et al., 2018",
      "attributes": {
        "year": 2018
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.9,
      "evidence": "Calipari et al., 2018",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "confidence": 0.8,
      "evidence": "prolonged cocaine administration",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Lewitus et al. (2016)",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.95,
      "evidence": "Lewitus et al. (2016) demonstrated",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.9,
      "evidence": "TNF-\u03b1 is increased in NAc after cocaine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "AMPA receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.85,
      "evidence": "inhibits AMPA receptor function",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "dopamine D1 receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.85,
      "evidence": "dopamine D1 receptor containing medium spiny neurons",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increased locomotor sensitization",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.8,
      "evidence": "TNF-\u03b1 knockouts showed increased locomotor sensitization",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduced cocaine sensitization",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.8,
      "evidence": "inhibition of TNF-\u03b1 signaling reduced cocaine sensitization",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Northcutt et al. (2015)",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.95,
      "evidence": "Northcutt et al., 2015",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "TLR-4",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.9,
      "evidence": "signaling via TLR-4 via IL-1\u03b2",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.9,
      "evidence": "IL-1\u03b2 enhanced behavioral response to cocaine",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "enhanced behavioral response to cocaine",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.85,
      "evidence": "IL-1\u03b2 enhanced behavioral response to cocaine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "cocaine-induced dopamine release",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.85,
      "evidence": "cocaine-induced dopamine release into the NAc",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "confidence": 0.7,
      "evidence": "microglial production of TNF-\u03b1 is increased",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "MCP-1",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.9,
      "evidence": "MCP-1",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "increased locomotor activity",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.85,
      "evidence": "increased locomotor activity",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "increased striatal dopamine release",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.85,
      "evidence": "increased striatal dopamine release",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Guyon et al., 2009",
      "attributes": {
        "year": 2009
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.8,
      "evidence": "Guyon et al., 2009",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "CCR2",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.9,
      "evidence": "C-C chemokine receptor 2 (CCR2)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decreased locomotor sensitization to cocaine",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.85,
      "evidence": "decreased locomotor sensitization to cocaine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "decreased activation of the ERK signaling cascade in the striatum",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.85,
      "evidence": "decreased activation of the ERK signaling cascade",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Trocello et al., 2011",
      "attributes": {
        "year": 2011
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.8,
      "evidence": "Trocello et al., 2011",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "SDF-1",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.9,
      "evidence": "stromal cell-derived factor 1 (SDF-1)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Araos et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.8,
      "evidence": "Araos et al., 2015",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "potentiates the locomotor response to cocaine",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.85,
      "evidence": "potentiates the locomotor response to cocaine",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Trecki & Unterwald, 2009",
      "attributes": {
        "year": 2009
      },
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "confidence": 0.8,
      "evidence": "Trecki & Unterwald, 2009",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "gut-immune-brain axis",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "confidence": 0.9,
      "evidence": "gut-immune-brain axis",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "addictive disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "confidence": 0.85,
      "evidence": "addictive disorders",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "cocaine use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "confidence": 0.9,
      "evidence": "cocaine use disorder",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Volpe et al. (2014)",
      "attributes": {
        "year": 2014
      },
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "confidence": 0.85,
      "evidence": "Volpe et al. (2014)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "confidence": 0.8,
      "evidence": "examined patients with cocaine use disorder",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "altered gut microbiome",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "confidence": 0.85,
      "evidence": "altered gut microbiome",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "increased bacterial translocation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "confidence": 0.8,
      "evidence": "increased bacterial translocation",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "pro-inflammatory state",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "confidence": 0.8,
      "evidence": "pro-inflammatory state",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "gut microbiome",
      "attributes": {},
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.95,
      "evidence": "microbiome can affect the behavioral response",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "altered behavioral response to drugs of abuse",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.85,
      "evidence": "microbiome can affect the behavioral response to drugs of abuse",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Kiraly et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.9,
      "evidence": "Kiraly et al., 2016",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.8,
      "evidence": "knockdown of the gut microbiome with broad spectrum antibiotics",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "cocaine",
      "attributes": {
        "target_type": "drug"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.9,
      "evidence": "CPP and locomotor sensitization to cocaine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "increased sensitivity to rewarding and sensitizing effects",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.85,
      "evidence": "more sensitive to the rewarding and sensitizing effects of cocaine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "NAc gene expression",
      "attributes": {
        "target_type": "gene expression"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.8,
      "evidence": "gene expression in the NAc",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "BDNF",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.9,
      "evidence": "brain derived neurotrophic factor (BDNF)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "D1 dopamine receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.85,
      "evidence": "D1 dopamine receptors",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "D2 dopamine receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.85,
      "evidence": "D2 dopamine receptors",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "GluR2 AMPA receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.85,
      "evidence": "GluR2 AMPA receptors",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "increased levels of BDNF and dopamine receptors",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.8,
      "evidence": "increased levels of brain derived neurotrophic factor (BDNF), D1 and D2 dopamine receptors",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Ning et al., 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.9,
      "evidence": "Ning et al., 2017",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.8,
      "evidence": "rats were injected every other day with methamphetamine",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "methamphetamine",
      "attributes": {
        "target_type": "drug"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.9,
      "evidence": "injected every other day with methamphetamine",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "modest increases in bacterial diversity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.75,
      "evidence": "modest increases in bacterial diversity after methamphetamine",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "small shifts in families of bacteria",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.75,
      "evidence": "small shifts in families of bacteria",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "decrease in caecal content of propionate",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.8,
      "evidence": "decrease in caecal content of the short chain fatty acid propionate",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Target",
      "name": "short chain fatty acids",
      "attributes": {
        "target_type": "metabolite"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.85,
      "evidence": "short chain fatty acids by the gut microbiota",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Target",
      "name": "blood-brain barrier integrity",
      "attributes": {
        "target_type": "barrier"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.8,
      "evidence": "integrity of the blood-brain barrier",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "confidence": 0.9,
      "evidence": "pathophysiology of addictive behaviors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Studies measuring cytokine release in human cells",
      "attributes": {
        "design": "in vitro"
      },
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "confidence": 0.8,
      "evidence": "Studies measuring cytokine release in human cells",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "confidence": 0.7,
      "evidence": "human cells",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "cytokine release",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "confidence": 0.85,
      "evidence": "cytokine release",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "mixed results",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "confidence": 0.75,
      "evidence": "mixed results",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "heroin use",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "confidence": 0.9,
      "evidence": "heroin users",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "higher levels of circulatory inflammatory cytokines",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "confidence": 0.85,
      "evidence": "higher levels of circulatory inflammatory cytokines",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "TNF-alpha",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "confidence": 0.9,
      "evidence": "TNF-alpha",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "morphine",
      "attributes": {},
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.95,
      "evidence": "giving morphine to healthy volunteers",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "mu opioid receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.9,
      "evidence": "mu opioid receptor selective agonist",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "increased cytokine release",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.85,
      "evidence": "increased release of several cytokines",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decreased cytotoxic response",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.85,
      "evidence": "natural killer cells that produce less cytotoxic response",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "dampened immune cell activation",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.8,
      "evidence": "act to dampen immune cell activation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "heroin",
      "attributes": {},
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.95,
      "evidence": "Cells from heroin abusers",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "lower pro-inflammatory cytokines",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.85,
      "evidence": "lower levels of pro-inflammatory cytokines",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "decreased IFN-gamma production",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.8,
      "evidence": "decreased production of IFN-gamma",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Yeager et al., 1995",
      "attributes": {
        "year": 1995
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.9,
      "evidence": "Yeager et al., 1995",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Happel et al., 2008",
      "attributes": {
        "year": 2008
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.9,
      "evidence": "Happel et al., 2008",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Meijerink et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.9,
      "evidence": "Meijerink et al., 2015",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Peterson et al., 1987",
      "attributes": {
        "year": 1987
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.9,
      "evidence": "Peterson et al., 1987",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.85,
      "evidence": "in vitro stimulation",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "confidence": 0.8,
      "evidence": "healthy volunteers",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "opioids",
      "attributes": {},
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.95,
      "evidence": "chronic use of opioids",
      "verified": true
    },
    {
      "id": "E2",
      "type": "AdverseEvent",
      "name": "tolerance",
      "attributes": {},
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.9,
      "evidence": "tolerance, dependence, and addiction",
      "verified": true
    },
    {
      "id": "E3",
      "type": "AdverseEvent",
      "name": "dependence",
      "attributes": {},
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.9,
      "evidence": "tolerance, dependence, and addiction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "addiction",
      "attributes": {},
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.9,
      "evidence": "tolerance, dependence, and addiction",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "opioid receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.9,
      "evidence": "binding to opioid receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "GABA neurons",
      "attributes": {
        "target_type": "neuron"
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.85,
      "evidence": "inhibiting GABA neurons",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "dopamine neurons",
      "attributes": {
        "target_type": "neuron"
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.85,
      "evidence": "disinhibition of dopamine neurons",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.9,
      "evidence": "microglia are known to play important roles",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.85,
      "evidence": "These cells, along with astrocytes",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "glial inhibitors",
      "attributes": {},
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.9,
      "evidence": "glial inhibitors are being investigated",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "Ibudilast",
      "attributes": {},
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.95,
      "evidence": "Ibudilast, a glial inhibitor",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.9,
      "evidence": "decrease TNF-\u03b1 release",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Condition",
      "name": "morphine withdrawal",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.85,
      "evidence": "attenuated subjective morphine withdrawal",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Condition",
      "name": "heroin dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.85,
      "evidence": "heroin-dependent individuals",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Johnson & North, 1992",
      "attributes": {
        "year": 1992
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Johnson & North, 1992",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Study",
      "name": "Yaksh, 1981",
      "attributes": {
        "year": 1981
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Yaksh, 1981",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Study",
      "name": "Miguel-Hidalgo, 2009",
      "attributes": {
        "year": 2009
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Miguel-Hidalgo, 2009",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Study",
      "name": "Sofroniew, 2013",
      "attributes": {
        "year": 2013
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Sofroniew, 2013",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Study",
      "name": "Salter & Stevens, 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Salter & Stevens, 2017",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Study",
      "name": "Bachtell et al., 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Bachtell et al., 2017",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Study",
      "name": "Suzumura et al., 1999",
      "attributes": {
        "year": 1999
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Suzumura et al., 1999",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Study",
      "name": "Cooper et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Cooper et al., 2016",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Study",
      "name": "Metz et al., 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "confidence": 0.8,
      "evidence": "Metz et al., 2017",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Study",
      "name": "Meng et al., 2015",
      "attributes": {},
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "confidence": 0.9,
      "evidence": "Meng et al., 2015",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Evidence",
      "name": "in vitro study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "confidence": 0.8,
      "evidence": "applied in vitro",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Compound",
      "name": "opioids",
      "attributes": {},
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "confidence": 0.85,
      "evidence": "treated with opioids",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decreased survival rates",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "confidence": 0.8,
      "evidence": "decreased survival rates",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "produce less IFN-gamma",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "confidence": 0.85,
      "evidence": "produce less IFN-gamma",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "morphine",
      "attributes": {},
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "confidence": 0.9,
      "evidence": "morphine",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "HIV protein Tat-1",
      "attributes": {},
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "confidence": 0.85,
      "evidence": "HIV protein Tat-1",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "potentiates Tat-1-induced IL-6, IL-10, MCP-1, MCP-5, and RANTES",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "confidence": 0.8,
      "evidence": "potentiates Tat-1-induced IL-6, IL-10, MCP-1, MCP-5, and RANTES",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "microglia",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.9,
      "evidence": "inhibition of microglia",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "astrocytes",
      "attributes": {
        "target_type": "cell"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.9,
      "evidence": "inhibition of microglia or astrocytes",
      "verified": true
    },
    {
      "id": "E3",
      "type": "AdverseEvent",
      "name": "tolerance",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.85,
      "evidence": "development of tolerance",
      "verified": true
    },
    {
      "id": "E4",
      "type": "AdverseEvent",
      "name": "physical dependence",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.85,
      "evidence": "physical dependence",
      "verified": true
    },
    {
      "id": "E5",
      "type": "AdverseEvent",
      "name": "morphine reward",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.85,
      "evidence": "morphine reward",
      "verified": true
    },
    {
      "id": "E6",
      "type": "AdverseEvent",
      "name": "reinstatement of morphine CPP",
      "attributes": {
        "severity": "not specified"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.85,
      "evidence": "reinstatement of morphine CPP",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.9,
      "evidence": "IL-1\u03b2 seems to be a crucial mediator",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "morphine's analgesic effect",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.8,
      "evidence": "morphine's analgesic effects",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "fractalkine",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.85,
      "evidence": "inhibition of fractalkine",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "IL-6",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "confidence": 0.85,
      "evidence": "inhibition of fractalkine and IL-6",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "confidence": 0.95,
      "evidence": "TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "morphine tolerance",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "confidence": 0.9,
      "evidence": "morphine tolerance",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "acute nociceptive responses",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "confidence": 0.85,
      "evidence": "acute nociceptive responses",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Hutchinson et al., 2008a",
      "attributes": {
        "year": 2008
      },
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "confidence": 0.8,
      "evidence": "Hutchinson et al., 2008a",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Eidson et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "confidence": 0.8,
      "evidence": "Eidson et al., 2016",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Niwa et al., 2007",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "confidence": 0.8,
      "evidence": "Niwa et al., 2007",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "in vitro",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "confidence": 0.7,
      "evidence": "Some studies demonstrate",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Effect",
      "name": "potentiated reinstatement of morphine CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.9,
      "evidence": "potentiated reinstatement of morphine CPP",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "pro-inflammatory signaling",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.85,
      "evidence": "Enhanced pro-inflammatory signaling",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "opioid reward mechanisms",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.85,
      "evidence": "opioid reward mechanisms",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "IFN-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.9,
      "evidence": "IFN-\u03b1 alone",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Lang et al., 2009",
      "attributes": {
        "year": 2009
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.8,
      "evidence": "Lang et al., 2009",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reduced rewarding effects of opioids",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.85,
      "evidence": "reduce the rewarding effects of opioids",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "anti-inflammatory processes",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.85,
      "evidence": "anti-inflammatory processes",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "IL-10",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.9,
      "evidence": "anti-inflammatory cytokine IL-10",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "decreased activation of microglia",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.9,
      "evidence": "decreased activation of microglia",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "decreased reinstatement of morphine CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.9,
      "evidence": "reinstatement of morphine CPP",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "decreased acquisition of self-administration of remifentanil",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.85,
      "evidence": "acquisition of self-administration of remifentanil",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Schwarz et al., 2011; Lacagnina et al., 2017a",
      "attributes": {
        "year": "2011, 2017"
      },
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "confidence": 0.8,
      "evidence": "Schwarz et al., 2011; Lacagnina et al., 2017a",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "morphine",
      "attributes": {},
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.95,
      "evidence": "Morphine and other opioids",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "opioid receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.9,
      "evidence": "bind opioid receptors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reward",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.85,
      "evidence": "produce reward",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "dependence",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.85,
      "evidence": "dependence",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "analgesia",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.85,
      "evidence": "analgesia",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "TLR4",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.9,
      "evidence": "bind TLR4",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "(+)-naloxone",
      "attributes": {},
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.9,
      "evidence": "(+)-naloxone",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "(+)-naltrexone",
      "attributes": {},
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.9,
      "evidence": "(+)-naltrexone",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "morphine tolerance",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.8,
      "evidence": "reverse morphine tolerance",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "morphine's analgesic effect",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.8,
      "evidence": "enhance morphine's analgesic effect",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "morphine CPP",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.75,
      "evidence": "impaired the development of morphine CPP",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "self-administration of remifentanil",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.75,
      "evidence": "self-administration of remifentanil",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "incubation of heroin craving",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.75,
      "evidence": "incubation of heroin craving",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "microglial activation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.7,
      "evidence": "enhanced microglial activation",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "opioid reward",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "confidence": 0.7,
      "evidence": "do not affect opioid reward",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "hepatic encephalopathy",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.9,
      "evidence": "patients with hepatic encephalopathy (HE)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Study",
      "name": "Acharya et al., 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.85,
      "evidence": "Acharya et al., 2017",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Evidence",
      "name": "clinical study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.8,
      "evidence": "human opioid users",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Study",
      "name": "Meng et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.85,
      "evidence": "Meng et al., 2015",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Banerjee et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.85,
      "evidence": "Banerjee et al., 2016",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Kang et al., 2017",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.85,
      "evidence": "Kang et al., 2017",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Wang et al., 2018",
      "attributes": {
        "year": 2018
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.85,
      "evidence": "Wang et al., 2018",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Evidence",
      "name": "rodent study",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.8,
      "evidence": "studies in rodents",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "morphine",
      "attributes": {},
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.95,
      "evidence": "morphine",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "increased systemic spread of bacteria",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.8,
      "evidence": "increased systemic spread of bacteria",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "altered proportion of gram-negative to gram-positive bacteria",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.8,
      "evidence": "altered the proportion of gram-negative to gram-positive bacteria",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "morphine analgesic tolerance",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.9,
      "evidence": "development of morphine analgesic tolerance",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Taxon",
      "name": "Enterococcus faecalis",
      "attributes": {
        "rank": "species"
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.9,
      "evidence": "Enterococcus faecalis",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "accelerated development of morphine tolerance",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.8,
      "evidence": "accelerated the development of morphine tolerance",
      "verified": true
    },
    {
      "id": "E15",
      "type": "RawMaterial",
      "name": "oral antibiotics",
      "attributes": {},
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.75,
      "evidence": "oral antibiotics",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "attenuated morphine tolerance",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "confidence": 0.8,
      "evidence": "attenuated morphine tolerance",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "morphine",
      "attributes": {},
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "confidence": 0.95,
      "evidence": "morphine on bacterial spread",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "IL-17A",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "confidence": 0.9,
      "evidence": "dependent on IL-17A",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Study",
      "name": "Meng et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "confidence": 0.85,
      "evidence": "Meng et al., 2015",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Evidence",
      "name": "in vivo study",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "confidence": 0.8,
      "evidence": "Treatment with IL-17A antibody",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "increased survival",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "confidence": 0.85,
      "evidence": "increased survival after caecal ligation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decreased bacterial spread",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "confidence": 0.85,
      "evidence": "decreased bacterial spread",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "decreased IL-6 production",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "confidence": 0.85,
      "evidence": "decreased IL-6 production",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "restored intestinal epithelial barrier",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "confidence": 0.85,
      "evidence": "restored the intestinal epithelial barrier",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Compound",
      "name": "opioids",
      "attributes": {},
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "confidence": 0.95,
      "evidence": "opioids influence inflammation",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "upregulation of pro-inflammatory cytokines",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "confidence": 0.85,
      "evidence": "upregulation of pro-inflammatory cytokines",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "enhanced activation of microglia",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "confidence": 0.85,
      "evidence": "enhanced activation of microglia",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduction in immune response to pathogens",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "confidence": 0.8,
      "evidence": "reduction in the immune response to pathogens",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "disruption of intestinal permeability",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "confidence": 0.8,
      "evidence": "disruption of intestinal permeability",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "tolerance",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "confidence": 0.9,
      "evidence": "tolerance",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "confidence": 0.9,
      "evidence": "dependence",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "reward",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "confidence": 0.85,
      "evidence": "reward",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "pro-inflammatory IL-1\u03b2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "pro-inflammatory TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "IL-10",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "anti-inflammatory IL-10",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "G-CSF",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "G-CSF, which is primarily anti-inflammatory",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "cocaine use disorder",
      "attributes": {
        "condition_type": "substance use disorder"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.8,
      "evidence": "behavioral response to cocaine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "opioid use disorder",
      "attributes": {
        "condition_type": "substance use disorder"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.8,
      "evidence": "behavioral response to opioids",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "increased behavioral response",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.85,
      "evidence": "drives increased behavioral response",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "inhibited behavioral response",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.85,
      "evidence": "inhibits response to cocaine",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "reduced behavioral response",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.85,
      "evidence": "reduces behavioral response for opioids",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "enhanced behavioral response",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.85,
      "evidence": "enhances behavioral responses to cocaine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Study",
      "name": "Hutchinson et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "Hutchinson et al., 2012",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Study",
      "name": "Northcutt et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "Northcutt et al., 2015",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Study",
      "name": "Lewitus et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "Lewitus et al., 2016",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Study",
      "name": "Lacagnina et al., 2017a",
      "attributes": {
        "year": 2017
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "Lacagnina et al., 2017a",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Study",
      "name": "Calipari et al., 2018",
      "attributes": {
        "year": 2018
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.9,
      "evidence": "Calipari et al., 2018",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Evidence",
      "name": "animal model evidence",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "confidence": 0.8,
      "evidence": "animal models of substance use disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.9,
      "evidence": "Increases in TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "inhibit behavioral responding for psychostimulants",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.85,
      "evidence": "Increases in TNF-\u03b1 inhibit behavioral responding for both psychostimulants",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "inhibit behavioral responding for opioids",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.85,
      "evidence": "Increases in TNF-\u03b1 inhibit behavioral responding for opioids",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "IL-1b pathway",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.9,
      "evidence": "signaling through the IL-1b pathway",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "enhance behavioral response to cocaine",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.85,
      "evidence": "IL-1b pathway enhances behavioral response to cocaine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "enhance behavioral response to opioids",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.85,
      "evidence": "IL-1b pathway enhances behavioral response to opioids",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Study",
      "name": "Lewitus et al., 2016",
      "attributes": {
        "year": 2016
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.8,
      "evidence": "Lewitus et al., 2016",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Study",
      "name": "Niwa et al., 2007",
      "attributes": {
        "year": 2007
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.8,
      "evidence": "Niwa et al., 2007",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Study",
      "name": "Northcutt et al., 2015",
      "attributes": {
        "year": 2015
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.8,
      "evidence": "Northcutt et al., 2015",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Study",
      "name": "Hutchinson et al., 2012",
      "attributes": {
        "year": 2012
      },
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "confidence": 0.8,
      "evidence": "Hutchinson et al., 2012",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "Dopamine Receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.9,
      "evidence": "Dopamine Receptor (blue)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "AMPA Receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.9,
      "evidence": "AMPA Receptor (purple)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "NMDA Receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.9,
      "evidence": "NMDA Receptor (red)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "G-CSF Receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.9,
      "evidence": "G-CSF Receptor (pink)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Toll-Like Receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.9,
      "evidence": "Toll-Like Receptor (green)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Compound",
      "name": "G-CSF",
      "attributes": {},
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.85,
      "evidence": "G-CSF (pink circle)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Compound",
      "name": "TNF-\u03b1",
      "attributes": {},
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.85,
      "evidence": "TNF-\u03b1 (orange circle)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Compound",
      "name": "IL-1\u03b2",
      "attributes": {},
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.85,
      "evidence": "IL-1\u03b2 (teal circle)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Compound",
      "name": "IL-10",
      "attributes": {},
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.85,
      "evidence": "IL-10 (yellow circle)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "cocaine",
      "attributes": {},
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.8,
      "evidence": "Cocaine and opioids",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "opioids",
      "attributes": {},
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.8,
      "evidence": "Cocaine and opioids",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "c-Fos production",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.75,
      "evidence": "leading to c-Fos production",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "Stat activation",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.75,
      "evidence": "Stat activation",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "synaptic dopamine release enhancement",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.7,
      "evidence": "enhance synaptic dopamine release",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "inhibition of pro-inflammatory mediators",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "confidence": 0.7,
      "evidence": "inhibits pro-inflammatory mediators",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "G-CSF",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.9,
      "evidence": "Levels of G-CSF are increased by cocaine",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "c-Fos",
      "attributes": {
        "target_type": "gene"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.85,
      "evidence": "production of immediate early gene c-Fos",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "TNF-\u03b1",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.9,
      "evidence": "microglial production of TNF-\u03b1",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "AMPA receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.85,
      "evidence": "inhibit AMPA receptor function",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "toll-like receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.9,
      "evidence": "Via direct action on the toll-like receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "IL-1\u03b2",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.9,
      "evidence": "increase levels of IL-1\u03b2",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "IL-10",
      "attributes": {
        "target_type": "cytokine"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.9,
      "evidence": "The anti-inflammatory cytokine IL-10",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "substance use disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.95,
      "evidence": "models of substance use disorder",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "neuronal activation",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.8,
      "evidence": "G-CSF enhances neuronal activation",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "synaptic dopamine release",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.8,
      "evidence": "enhancing synaptic dopamine release",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "inhibition of pro-inflammatory mediators",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "confidence": 0.75,
      "evidence": "IL-10 inhibits production of pro-inflammatory mediators",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "CCL2",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL2, chemokine (C-C motif) ligand 2",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "CCL3",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL3, chemokine (C-C motif) ligand 3",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "CCL4",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL4, chemokine (C-C motif) ligand 4",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "CCL5",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL5, chemokine (C-C motif) ligand 5",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "CCL8",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL8, chemokine (C-C motif) ligand 8",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "CCL11",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL11, chemokine (C-C motif) ligand 11",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "CCL12",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL12, chemokine (C-C motif) ligand 12",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "CCL17",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL17, chemokine (C-C motif) ligand 17",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "CCL25",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CCL25, chemokine (C-C motif) ligand 25",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "CXCL1",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CXCL1, chemokine (C-X-C motif) ligand 1",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "CXCL9",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CXCL9, chemokine (C-X-C motif) ligand 9",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "CXCL12",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CXCL12, chemokine (C-X-C motif) ligand 12",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "CX3CL1",
      "attributes": {
        "target_type": "chemokine"
      },
      "source_chunk_ids": [
        "573654bbc1a372f38a1e51a55c6e5fc7"
      ],
      "confidence": 0.95,
      "evidence": "CX3CL1, chemokine (C-X3-C motif) ligand 1",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "In this review",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "condition"
      },
      "confidence": 0.85,
      "evidence": "substance use disorders",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "involves"
      },
      "confidence": 0.8,
      "evidence": "dysregulated immune signaling",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "contributes"
      },
      "confidence": 0.75,
      "evidence": "neuroimmune interactions",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "causal roles"
      },
      "confidence": 0.7,
      "evidence": "immune mediators",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "complex and important",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "brain-immune system interactions",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "seen"
      },
      "confidence": 0.8,
      "evidence": "immunological changes",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "contributes"
      },
      "confidence": 0.75,
      "evidence": "addictive behaviors",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "dysregulated immune signaling in pathophysiology",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "neuroimmune interactions to addictive behaviors",
      "source_chunk_ids": [
        "f0854ce17323ee1af42732ebb1050229"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "TREATS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "approved for nicotine use disorder",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E17"
      ],
      "verified": true
    },
    {
      "id": "R2",
      "type": "TREATS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "approved for nicotine use disorder",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E17"
      ],
      "verified": true
    },
    {
      "id": "R3",
      "type": "TREATS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "approved for alcohol use disorder",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E18"
      ],
      "verified": true
    },
    {
      "id": "R4",
      "type": "TREATS",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "approved for alcohol use disorder",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E18"
      ],
      "verified": true
    },
    {
      "id": "R5",
      "type": "TREATS",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.75,
      "evidence": "approved for alcohol use disorder",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E18"
      ],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "treatment is with opioid replacement therapies such as methadone",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "TREATS",
      "source_entity_id": "E12",
      "target_entity_id": "E4",
      "attributes": {
        "context": "clinical"
      },
      "confidence": 0.7,
      "evidence": "treatment is with opioid replacement therapies such as buprenorphine",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "CAUSES",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "myriad associated adverse effects",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E19",
        "E20"
      ],
      "verified": false
    },
    {
      "id": "R9",
      "type": "CAUSES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "myriad associated adverse effects",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E19",
        "E20"
      ],
      "verified": false
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E16",
      "attributes": {
        "action": "targets",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "Agonist therapies targeting dopaminergic systems",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E14",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "sexual dysfunction",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E22",
        "E23"
      ],
      "verified": false
    },
    {
      "id": "R12",
      "type": "CAUSES",
      "source_entity_id": "E6",
      "target_entity_id": "E15",
      "attributes": {
        "context": "clinical",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "weight gain",
      "source_chunk_ids": [
        "a94d77838f772bc55f41dc43555115aa"
      ],
      "supporting_study_ids": [
        "E22",
        "E23"
      ],
      "verified": false
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "role": "causal"
      },
      "confidence": 0.7,
      "evidence": "interactions... playing causal roles",
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "role": "causal"
      },
      "confidence": 0.7,
      "evidence": "interactions... playing causal roles",
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "role": "involved",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "inflammatory processes... in depression",
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "role": "involved",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "inflammatory processes... in schizophrenia",
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "role": "important",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "neuroimmune mechanisms... in addictive disorders",
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "role": "involved",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "neuroimmune processes... in illicit substance use disorders",
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "role": "treatment",
        "verification_needed": true
      },
      "confidence": 0.55,
      "evidence": "treatment targets in psychiatric disease",
      "source_chunk_ids": [
        "a44d0ca4ebf0b764a0ee9d486d38ef54"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "innate immune system mounts inflammatory response",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E12",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "PRRs detect foreign entities, leading to response",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "microglia mediate response in CNS",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E12",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "astrocytes contribute to immune responses",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Pro-inflammatory cytokines launch immune responses",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "modulates"
      },
      "confidence": 0.7,
      "evidence": "anti-inflammatory cytokines help maintain homeostasis",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "context": "prolonged"
      },
      "confidence": 0.8,
      "evidence": "prolonged inflammation can cause tissue damage",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "tissue damage contributes to chronic diseases",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E15",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "chronic diseases include psychiatric pathologies",
      "source_chunk_ids": [
        "0da26c5a1cde90e72e6e8bb39853aa34"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuroimmune interactions can lead to inflammatory changes",
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuroimmune interactions can lead to changes in brain systems",
      "source_chunk_ids": [
        "89b6c459b5e76058ccb8d49a65704745"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Healthy controls given a typhoid vaccination",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "increased activation"
      },
      "confidence": 0.8,
      "evidence": "increased activation of their substantia nigra",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "increased levels"
      },
      "confidence": 0.8,
      "evidence": "increased serum levels of IL-6",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "pro-inflammatory effects"
      },
      "confidence": 0.75,
      "evidence": "infusions of the interferon-\u03b1 (IFN-\u03b1) pro-inflammatory cytokine",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "reviewed link"
      },
      "confidence": 0.7,
      "evidence": "literature linking inflammation with altered dopaminergic signaling",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "reviewed link"
      },
      "confidence": 0.7,
      "evidence": "literature linking inflammation with altered dopaminergic signaling",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "drugs of abuse all work via increasing mesolimbic dopamine release",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E2",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "confidence": 0.85,
      "evidence": "inflammatory changes can affect dopamine signaling",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E9",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "confidence": 0.8,
      "evidence": "inflammatory conditions are capable of decreasing dopamine synthesis",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E10",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "confidence": 0.75,
      "evidence": "may even affect dopamine transporter function",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "SUGGESTS",
      "source_entity_id": "E15",
      "target_entity_id": "E1",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "possibility of inflammation and drug interactions to heighten these effects",
      "source_chunk_ids": [
        "5a04764828f5747785486c4fd41a03d8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "affects"
      },
      "confidence": 0.85,
      "evidence": "Inflammation has also been found to affect glutamatergic signaling",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "High levels of peripheral inflammation... are correlated with decreased functional connectivity",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "pro-inflammatory cytokines downregulate glutamate transporters",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "downregulate glutamate transporters... disrupting the homeostasis",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "glutamate transporters are downregulated in cocaine treated animals",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E4",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "increase in synaptic glutamate can contribute to relapse behaviors",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "action": "regulates"
      },
      "confidence": 0.8,
      "evidence": "TNF-\u03b1 cytokine is an important regulator of synaptic strength",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E14",
      "attributes": {
        "action": "affects"
      },
      "confidence": 0.7,
      "evidence": "effects of inflammation on this circuit",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E15",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "effects of inflammation... could have major implications for... substance use disorders",
      "source_chunk_ids": [
        "9b838ec4721a185bad10b4aaf82b5b2e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibition of the dopamine transporter",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibition of the dopamine transporter",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "increase levels of dopamine",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "increase levels of dopamine",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "engages"
      },
      "confidence": 0.75,
      "evidence": "cocaine itself may engage PRRs",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "create an inflammatory response",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "increases HIV replication rates",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "release of cortisol",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "release of cortisol",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "acutely anti-inflammatory effects",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "chronically pro-inflammatory effects",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "affect immune function",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "affect immune function",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E16",
      "attributes": {
        "context": "mechanistic"
      },
      "confidence": 0.7,
      "evidence": "addictive substances",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "TREATS",
      "source_entity_id": "E2",
      "target_entity_id": "E16",
      "attributes": {
        "context": "mechanistic"
      },
      "confidence": 0.7,
      "evidence": "addictive substances",
      "source_chunk_ids": [
        "7170a01d6eef1fbddf24b9cb02103141"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "cocaine addicts",
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "suggests"
      },
      "confidence": 0.75,
      "evidence": "suggestive of a central pro-inflammatory mechanism",
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "decreased number of dopamine cell bodies",
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "methamphetamine use disorder",
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "increased markers of microglial activation",
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Postmortem examination",
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PET studies",
      "source_chunk_ids": [
        "950bfa0045670a85e7573e47335263ad"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "PET imaging study",
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "condition"
      },
      "confidence": 0.9,
      "evidence": "patients with cocaine use disorder",
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "found no differences in binding",
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "PET tracers are known",
      "source_chunk_ids": [
        "882049cb461271ca6e60a3b438c1fc3f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "reviewed more extensively by Lacagnina et al., (2017b)",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "reviewed more extensively by Lacagnina et al., (2017b)",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "reviewed more extensively by Lacagnina et al., (2017b)",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.7,
      "evidence": "reviewed more extensively by Lacagnina et al., (2017b)",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "Methamphetamine has been repeatedly shown",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.85,
      "evidence": "induce microglial activation",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "induce microglial activation",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "inhibition of microglial activation via minocycline",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E10",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "via ibudilast",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.8,
      "evidence": "reduce the rewarding properties of stimulants",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.85,
      "evidence": "antagonist of the toll-like receptor 4 (TLR-4) ibudilast",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "inhibition of microglial activation via minocycline reduce the rewarding properties",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "via ibudilast reduce the rewarding properties",
      "source_chunk_ids": [
        "14778277192a1e5c17ee72773df8b1c7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.9,
      "evidence": "cocaine binds the TLR4 receptor",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "Zhang et al., 2014",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Northcutt et al., (2015)",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in silico and in vitro modeling",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.8,
      "evidence": "cocaine-induced dopamine release",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.8,
      "evidence": "conditioned place preference (CPP)",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "induces"
      },
      "confidence": 0.8,
      "evidence": "self-administration of cocaine",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E2",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "Kashima & Grueter, 2017",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "affects"
      },
      "confidence": 0.75,
      "evidence": "basal synaptic transmission",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "affects"
      },
      "confidence": 0.75,
      "evidence": "NMDA-dependent synaptic plasticity",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E2",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.8,
      "evidence": "Brown et al., 2018",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E13",
      "attributes": {
        "outcome": "affects"
      },
      "confidence": 0.8,
      "evidence": "reinstatement of cocaine seeking",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "STUDIES",
      "source_entity_id": "E14",
      "target_entity_id": "E15",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Tanda et al., 2016",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "ACTS_ON",
      "source_entity_id": "E15",
      "target_entity_id": "E2",
      "attributes": {
        "action": "antagonizes",
        "assertion": "refutes"
      },
      "confidence": 0.7,
      "evidence": "disputes the effects of the TLR4 antagonists",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.7,
      "evidence": "disputes the effects on dopamine release",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "SUGGESTS",
      "source_entity_id": "E2",
      "target_entity_id": "E16",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.75,
      "evidence": "potentially important line of translational research in the neurobiology of addiction",
      "source_chunk_ids": [
        "49515793327e1cb701a04a8d3b37f688"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Calipari et al., 2018",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "identified G-CSF as a cytokine",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "G-CSF treatment lead to increased neuronal activation",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.85,
      "evidence": "G-CSF enhanced cocaine CPP",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.85,
      "evidence": "G-CSF enhanced locomotor sensitization",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.85,
      "evidence": "G-CSF enhanced self-administration",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "G-CSF treatment lead to increased neuronal activation",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "G-CSF enhanced cocaine CPP",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "G-CSF enhanced locomotor sensitization",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "G-CSF enhanced self-administration",
      "source_chunk_ids": [
        "a8e7d7b67484d653ba101397253ad2fd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "increased"
      },
      "confidence": 0.85,
      "evidence": "TNF-\u03b1 is increased in NAc after cocaine",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "inhibits AMPA receptor function",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "increased"
      },
      "confidence": 0.75,
      "evidence": "TNF-\u03b1 knockouts showed increased locomotor sensitization",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "reduced"
      },
      "confidence": 0.75,
      "evidence": "inhibition of TNF-\u03b1 signaling reduced cocaine sensitization",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "involved"
      },
      "confidence": 0.8,
      "evidence": "signaling via TLR-4 via IL-1\u03b2",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.85,
      "evidence": "IL-1\u03b2 enhanced behavioral response to cocaine",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "enhanced"
      },
      "confidence": 0.8,
      "evidence": "IL-1\u03b2 enhanced behavioral response to cocaine",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "necessary"
      },
      "confidence": 0.8,
      "evidence": "necessary for cocaine-induced dopamine release",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "microglial production of TNF-\u03b1 is increased",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "signaling via TLR-4 via IL-1\u03b2",
      "source_chunk_ids": [
        "1e63f9d2e0fe2d4ea3b9dc5d6966b378"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "Infusions of MCP-1 result in increased locomotor activity",
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "Infusions of MCP-1 result in increased striatal dopamine release",
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "knockout of CCR2 leads to decreased locomotor sensitization",
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "knockout of CCR2 leads to decreased activation of ERK",
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.75,
      "evidence": "levels of SDF-1 are increased after cocaine exposure",
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "infusion of SDF-1 potentiates locomotor response to cocaine",
      "source_chunk_ids": [
        "ab13e1c527c78f0205e9fff57a129091"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Volpe et al. (2014) examined patients",
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "role": "condition"
      },
      "confidence": 0.9,
      "evidence": "examined patients with cocaine use disorder",
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "cocaine use disorder was an independent predictor of an altered gut microbiome",
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "suggestive"
      },
      "confidence": 0.75,
      "evidence": "suggestive of increased bacterial translocation",
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "may result in a pro-inflammatory state",
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "growing evidence that alterations in the gut microbiome might be playing a role in the development of addictive disorders",
      "source_chunk_ids": [
        "b0469df33bc1321decfc9884af372e38"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "microbiome can affect the behavioral response to drugs of abuse",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Kiraly et al., 2016",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "knockdown of the gut microbiome",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "affects"
      },
      "confidence": 0.85,
      "evidence": "CPP and locomotor sensitization to cocaine",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "more sensitive to the rewarding and sensitizing effects of cocaine",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "affects"
      },
      "confidence": 0.75,
      "evidence": "gene expression in the NAc",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "increased levels of BDNF and dopamine receptors",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "depletion of the microbiome affected gene expression",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Ning et al., 2017",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E13",
      "target_entity_id": "E15",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.9,
      "evidence": "injected every other day with methamphetamine",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.75,
      "evidence": "modest increases in bacterial diversity after methamphetamine",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E17",
      "attributes": {
        "outcome": "shifts"
      },
      "confidence": 0.75,
      "evidence": "small shifts in families of bacteria",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E18",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "decrease in caecal content of propionate",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E19",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "short chain fatty acids by the gut microbiota",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E19",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "implicated in the integrity of the blood-brain barrier",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E21",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "gut-immune-brain connection in addiction",
      "source_chunk_ids": [
        "b8183b390a437984cd6964154a680cae"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Studies measuring cytokine release in human cells",
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "target"
      },
      "confidence": 0.85,
      "evidence": "measuring cytokine release",
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "mixed"
      },
      "confidence": 0.75,
      "evidence": "mixed results",
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.7,
      "evidence": "heroin users",
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "higher levels of circulatory inflammatory cytokines",
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "heroin users have higher levels",
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "inflammatory cytokines such as TNF-alpha",
      "source_chunk_ids": [
        "c4fa5bb69a296a26b2673ad71fba022f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "agonist"
      },
      "confidence": 0.85,
      "evidence": "mu opioid receptor selective agonist",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "morphine increased release of several cytokines",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "morphine results in less cytotoxic response",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "opioids act to dampen immune cell activation",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "heroin abusers have lower pro-inflammatory cytokines",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "morphine decreased production of IFN-gamma",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E9",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Yeager et al., 1995 studied morphine",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Happel et al., 2008 studied morphine",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E11",
      "target_entity_id": "E6",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Meijerink et al., 2015 studied heroin",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E12",
      "target_entity_id": "E1",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Peterson et al., 1987 studied morphine",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E9",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "healthy volunteers study",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "in vitro stimulation",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "reported less cytotoxic response",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.8,
      "evidence": "reported increased cytokine release",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "reported lower pro-inflammatory cytokines",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "reported decreased IFN-gamma production",
      "source_chunk_ids": [
        "255674f0477537424cf2d49d2953f29d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "tolerance, dependence, and addiction",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "tolerance, dependence, and addiction",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "CAUSES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "tolerance, dependence, and addiction",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.9,
      "evidence": "binding to opioid receptors",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "inhibiting GABA neurons",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "disinhibition of dopamine neurons",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E8",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "glial inhibitors are being investigated",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {
        "action": "decreases"
      },
      "confidence": 0.85,
      "evidence": "decrease TNF-\u03b1 release",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "attenuated subjective morphine withdrawal",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [
        "E22"
      ],
      "verified": true
    },
    {
      "id": "R10",
      "type": "TREATS",
      "source_entity_id": "E11",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "motivation for low-dose oxycodone",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [
        "E23"
      ],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Johnson & North, 1992",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E16",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Yaksh, 1981",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E17",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Miguel-Hidalgo, 2009",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E18",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Sofroniew, 2013",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "REPORTS",
      "source_entity_id": "E19",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Salter & Stevens, 2017",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "REPORTS",
      "source_entity_id": "E20",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Bachtell et al., 2017",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E21",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Suzumura et al., 1999",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "REPORTS",
      "source_entity_id": "E22",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Cooper et al., 2016",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "REPORTS",
      "source_entity_id": "E23",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Metz et al., 2017",
      "source_chunk_ids": [
        "c81e71a21d7723bd252bb70e64cf3226"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Meng et al., 2015",
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "STUDIES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.8,
      "evidence": "treated with opioids",
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.75,
      "evidence": "decreased survival rates",
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "produce less IFN-gamma",
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "INTERACTS_WITH",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {
        "interaction_type": "combination",
        "bidirectional": true
      },
      "confidence": 0.85,
      "evidence": "morphine in combination with HIV protein Tat-1",
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "potentiates Tat-1-induced IL-6, IL-10, MCP-1, MCP-5, and RANTES",
      "source_chunk_ids": [
        "f539149127af5c28ff8f73081d2ac01f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "inhibition of microglia ... decrease ... tolerance",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "inhibition of microglia ... decrease ... physical dependence",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "inhibition of microglia ... decrease ... morphine reward",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "inhibition of microglia ... decrease ... reinstatement of morphine CPP",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "inhibition of ... astrocytes ... decrease ... tolerance",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "inhibition of ... astrocytes ... decrease ... physical dependence",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "inhibition of ... astrocytes ... decrease ... morphine reward",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.8,
      "evidence": "inhibition of ... astrocytes ... decrease ... reinstatement of morphine CPP",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "action": "mediates"
      },
      "confidence": 0.75,
      "evidence": "IL-1\u03b2 seems to be a crucial mediator of morphine's analgesic effects",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "inhibition of fractalkine ... produced a reduction in morphine tolerance",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "decreases"
      },
      "confidence": 0.75,
      "evidence": "inhibition of ... IL-6 also produced a reduction in morphine tolerance",
      "source_chunk_ids": [
        "9f8b441affdb22e8e0c80aabfaea3dff"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "inhibition of TNF-\u03b1 reduced or reversed morphine tolerance",
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.75,
      "evidence": "inhibition of TNF-\u03b1 reduced or reversed morphine tolerance",
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "knockout of TNF-\u03b1 did not affect tolerance",
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "no_effect"
      },
      "confidence": 0.8,
      "evidence": "knockout of TNF-\u03b1 did not affect acute nociceptive responses",
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Some studies demonstrate",
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Some studies demonstrate",
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "another study suggested",
      "source_chunk_ids": [
        "63453d30fb5b094ddb97b7a47c71b3f5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Enhanced pro-inflammatory signaling seems to potentiate opioid reward mechanisms",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Enhanced pro-inflammatory signaling seems to potentiate opioid reward mechanisms",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "When given IFN-\u03b1 alone, rats showed potentiated reinstatement of morphine CPP",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Lang et al., 2009",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "upregulation of anti-inflammatory processes may counteract inflammatory actions and reduce the rewarding effects of opioids",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "Overexpression of the anti-inflammatory cytokine IL-10 decreased activation of microglia",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.9,
      "evidence": "IL-10 decreased reinstatement of morphine CPP",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "IL-10 decreased acquisition of self-administration of remifentanil",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Schwarz et al., 2011; Lacagnina et al., 2017a",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Schwarz et al., 2011; Lacagnina et al., 2017a",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Schwarz et al., 2011; Lacagnina et al., 2017a",
      "source_chunk_ids": [
        "03f0dba9c2c4a217fe4c9c7d55baa605"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.9,
      "evidence": "bind opioid receptors",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "produce reward",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "dependence",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "analgesia",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.7,
      "evidence": "opioids bind TLR4",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.8,
      "evidence": "putative antagonists at TLR4",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E8",
      "target_entity_id": "E6",
      "attributes": {
        "action": "antagonist"
      },
      "confidence": 0.8,
      "evidence": "putative antagonists at TLR4",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "reverses"
      },
      "confidence": 0.75,
      "evidence": "reverse morphine tolerance",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "reverses"
      },
      "confidence": 0.75,
      "evidence": "reverse morphine tolerance",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.75,
      "evidence": "enhance morphine's analgesic effect",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.75,
      "evidence": "enhance morphine's analgesic effect",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "enhanced microglial activation",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "no_effect",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "do not affect opioid reward",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E15",
      "attributes": {
        "outcome": "no_effect",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "do not affect opioid reward",
      "source_chunk_ids": [
        "cbf0c320530382ff6d995ca8d7d7a74e"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "Acharya et al., 2017",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "patients with hepatic encephalopathy",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Meng et al., 2015",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Banerjee et al., 2016",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Kang et al., 2017",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Wang et al., 2018",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "STUDIES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "experimenter-administered morphine",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "STUDIES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "morphine",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "morphine tolerance",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "morphine tolerance",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "increased systemic spread of bacteria",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "altered the proportion of gram-negative to gram-positive bacteria",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "altered the proportion of gram-negative to gram-positive bacteria",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E12",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.85,
      "evidence": "development of morphine analgesic tolerance",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "CAUSES",
      "source_entity_id": "E9",
      "target_entity_id": "E12",
      "attributes": {
        "context": "experimental"
      },
      "confidence": 0.8,
      "evidence": "directly contributes to the development of morphine analgesic tolerance",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [
        "E4",
        "E5",
        "E6",
        "E7"
      ],
      "verified": true
    },
    {
      "id": "R16",
      "type": "STUDIES",
      "source_entity_id": "E7",
      "target_entity_id": "E13",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.85,
      "evidence": "Enterococcus faecalis",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E14",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "accelerated the development of morphine tolerance",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "STUDIES",
      "source_entity_id": "E6",
      "target_entity_id": "E15",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "oral antibiotics",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E16",
      "attributes": {
        "outcome": "causes"
      },
      "confidence": 0.8,
      "evidence": "attenuated morphine tolerance",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "directly contributes to the development",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R21",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "directly contributes to the development",
      "source_chunk_ids": [
        "2f0d68e2bf526ec941e9a64e6f5794d1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "morphine on bacterial spread are dependent on IL-17A",
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Meng et al., 2015",
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "STUDIES",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "role": "intervention"
      },
      "confidence": 0.75,
      "evidence": "Treatment with IL-17A antibody",
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "increased survival after caecal ligation",
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "decreased bacterial spread",
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "decreased IL-6 production",
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "improves"
      },
      "confidence": 0.8,
      "evidence": "restored the intestinal epithelial barrier",
      "source_chunk_ids": [
        "e6abb415fce9add31dcf533dbc6863d4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "upregulation of pro-inflammatory cytokines after opioid exposure",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "enhanced activation of microglia resulting from opioid intake",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "reduction in the immune response to pathogens",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "disruption of intestinal permeability",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contribute to tolerance",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contribute to dependence",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contribute to reward",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contribute to tolerance",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contribute to dependence",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "contribute to reward",
      "source_chunk_ids": [
        "b41784bfa586f03918dd9a0e64208ded"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E11",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.85,
      "evidence": "IL-1\u03b2 drives increased behavioral response",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "increases"
      },
      "confidence": 0.85,
      "evidence": "IL-1\u03b2 drives increased behavioral response",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "inhibits"
      },
      "confidence": 0.85,
      "evidence": "TNF-\u03b1 inhibits response to cocaine",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E14",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "reduces"
      },
      "confidence": 0.85,
      "evidence": "IL-10 reduces behavioral response for opioids",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E15",
      "target_entity_id": "E10",
      "attributes": {
        "outcome": "enhances"
      },
      "confidence": 0.85,
      "evidence": "G-CSF enhances behavioral responses to cocaine",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "IL-1\u03b2 drives increased behavioral response",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "TNF-\u03b1 inhibits response to cocaine",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "IL-10 reduces behavioral response for opioids",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "G-CSF enhances behavioral responses to cocaine",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E11",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "animal models of substance use disorders",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E12",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "animal models of substance use disorders",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E13",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "animal models of substance use disorders",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E14",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "animal models of substance use disorders",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "animal models of substance use disorders",
      "source_chunk_ids": [
        "50a15928e4c629e7223e960636fec5d6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Increases in TNF-\u03b1 inhibit behavioral responding for psychostimulants",
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Increases in TNF-\u03b1 inhibit behavioral responding for opioids",
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "IL-1b pathway enhances behavioral response to cocaine",
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "IL-1b pathway enhances behavioral response to opioids",
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Lewitus et al., 2016",
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Niwa et al., 2007",
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Northcutt et al., 2015",
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Hutchinson et al., 2012",
      "source_chunk_ids": [
        "9258a0da51f7aaa1e55dc27ef8fed0e3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "action": "binds"
      },
      "confidence": 0.8,
      "evidence": "G-CSF binding to its receptor",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "leading to c-Fos production",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Stat activation",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "Cocaine inhibiting AMPA receptors",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E11",
      "target_entity_id": "E2",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "opioids inhibiting AMPA receptors",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Cocaine increasing IL-1\u03b2 levels",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "opioids increasing IL-1\u03b2 levels",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E14",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "IL-1\u03b2 enhance synaptic dopamine release",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "Opioids upregulating IL-10",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "IL-10 inhibits pro-inflammatory mediators by toll-like receptors",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E15",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "IL-10 inhibits pro-inflammatory mediators",
      "source_chunk_ids": [
        "a509a27376da5efc55bdb53273186606"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "G-CSF enhances neuronal activation",
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "G-CSF enhances production of c-Fos",
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.8,
      "evidence": "TNF-\u03b1 inhibit AMPA receptor function",
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "IL-1\u03b2 enhancing synaptic dopamine release",
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "action": "inhibits"
      },
      "confidence": 0.7,
      "evidence": "IL-10 inhibits production by toll-like receptors",
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "IL-10 inhibits production of pro-inflammatory mediators",
      "source_chunk_ids": [
        "be8de7f5b0bcf6d3efa3dea209835ec5"
      ],
      "supporting_study_ids": [],
      "verified": true
    }
  ]
}